Hematolymphoid tumors of the mediastinum
2024-05-09 Paola Dal Cin, PhD , Judy A. Ferry Affiliation1.Brigham and Women's Hospital , Harvard Medical School, Boston , MA (USA)
2.Massachusetts General Hospital, Harvard Medical School Boston (MA) USAl
Keywords
Mediastinal lymphoma, B-cell lymphoma, mediastinumClassification
Definition
A variety of lymphomas arises in the mediastinum, often from the thymus. These include primary mediastinal large B-cell lymphoma, some cases of nodular sclerosis classic Hodgkin lymphoma, mediastinal gray zone lymphoma, thymic marginal zone lymphoma of mucosa-associated lymphoid tissue, and T lymphoblastic leukemia/ lymphoma. Primary mediastinal large B-cell lymphoma (PMBCL) is an aggressive B-cell lymphoma of putative thymic B-cell origin, having distinctive clinical and pathologic features. 1 Classic Hodgkin lymphoma is characterized by a small number of highly abnormal neoplastic B cells in an abundant microenvironment; the most common type of Hodgkin lymphoma to involve the mediastinum is nodular sclerosis classic Hodgkin lymphoma (NSCHL). PMBCL and NSCHL share a number of clinical and pathologic features, and in a small number of cases it may be difficult to distinguish between these two types of lymphoma. The term “mediastinal gray zone lymphoma” has been adopted to describe cases of aggressive B-cell lymphomas with overlapping features between PMBCL and classic Hodgkin lymphoma, in particular NSCHL. 2 Rare cases of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL) arise in the thymus; they have characteristic clinical and pathologic features that distinguish them EMZL arising in other sites. 3,4 The thymus is the most common site of origin for T lymphoblastic lymphoma, a primitive aggressive neoplasm committed to T lineage. The term T lymphoblastic leukemia is used for those cases primarily involving bone marrow and peripheral blood.
In addition to lymphoma, rare cases of follicular dendritic cell sarcoma 5 and myeloid sarcoma6 arise in the mediastinum; these neoplasms may enter the differential diagnosis of lymphoma.
| Hematolymphoid tumors of the mediastinum | Genetic markers(s) |
|---|---|
| Primary mediastinal large B-cell lymphoma (PMBCL) | PMBCL is large B-cell lymphoma arising from the thymus, predominantly in young adult females, showing distinctive clinical, immunophenotypic and genetic features. Gene expression profiling has shown some molecular features reminiscent of nodular sclerosis classic Hodgkin lymphoma (cHL). PMBCL is characterized by activation of NF-κB 7 and JAK/STAT signalling pathways,8 and by alterations promoting immune escape.9-11 Recurrent somatic mutations of SOCS1, GNA13, STAT6, B2M and others; copy number alterations, in particular amplification of 2p16.1 REL and of 9p24.1 CD274/ PDCD1LG2/JAK2 and deletions of 6q23 TNFAIP3, 9p21 CDKN2A, and 17p13 TP53; 12 and translocation of 16p13 /CIITA are described. No MYC or BCL2 translocations are reported. BCL6 mutation is more common than translocation.13 A recent large-scale genomic characterization of PMBCL detected a total of 50 candidate PMBCL drivers, with 24 of them not previously reported in PMBCL and four of them [PLXNC1, SZT2,CD80, and LHFPL3], not reported in any lymphoma. In addition, novel treatment targets and genetic lesions were identified for refined risk stratification, mainly adverse prognostic significance of the CD58 mutation status and durable responses for DUSP2-mutated patients.14 Interesting , rarely, DLBCL cases with a non-mediastinal location may show a molecular signature reminiscent of PMBCL. 15 |
| Mediastinal (thymic) extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | MALT lymphomas arising in thymus are rare; they preferentially affect Asian women and are strongly associated with autoimmune disease, especially Sjögren syndrome OMIM:270150. Translocations of MALT1 and IGH have been absent. 4,16,17,17,18,18 Trisomy 3 is common (40-50%)3,17and trisomy 18 is occasionally found (7% in two reports).3,17. One case with dup(X)(p22p11)19 and one with add(8)(q24) (not involving MYC) are described.4 In one small series, most cases carried mutations of one or more genes (e.g., TNFAIP3, CARD11) expected to result in NFkB pathway activation, suggesting NFkB dysregulation plays a major role in the pathogenesis of thymic MALT lymphoma.18 One case showed mutated CCND3, suggesting that PI3K pathway activation may also have a role in lymphomagenesis.18 Frequent methylation of tumor suppressor genes, including DAPK1, CDH1, TIMP3 and p14ARF, is also described.3 Evaluation of immunoglobulin (Ig) genes shows Vh usage restricted to the Vh3 family and biased toward Vh3-30 and Vh3-23, both often expressed by autoimmune B cells.20 Jh segment usage is confined to Jh4.20 Somatic hypermutation of Ig genes is absent. The findings suggest that specific antigens may play a role in the genesis of thymic MALT lymphoma.20 |
| Mediastinal T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) | The mediastinum (specifically, the thymus) is the most common primary site for T lymphoblastic lymphoma. Mediastinal T-LBL occurs more frequently in children and young adults. However, no specific molecular studies are available regarding mediastinal T-LBL 21 T-ALL/LBL shows clonal rearrangement of T-cell receptor (TCR) genes and, in up to 20% of cases, and may show concurrent clonal IGH rearrangement.22-24 The karyotype is abnormal in most cases; translocations involving TCR genes TCRα/d, TCRβ, and TCRγ] are common, with multiple different partners. In addtion deletion of 9p/CDKN2A, mutations of NOTCH1, FBXW7 and TP53 are recurrent. 25 T-ALL/LBL can be divided into five main genetic subgroups, corresponding to arrested maturation at different stages: (1) the TAL/LMO subgroup; (2) the TLX1 activation subgroup; (3) the TLX3 subgroup; (4) the HOXA subgroup; and (5) the MYB oncogene activation subgroup.26,26,27 |
| Mediastinal classic Hodgkin lymphoma (cHL) | Nodular sclerosis cHL is by far the most common type of Hodgkin lymphoma to involve the mediastinum. Hodgkin/Reed-Sternberg (HRS) cells show clonal rearrangement of IGH and somatic hypermutation of IGHV (highly sensitive techniques usually required to demonstrate these changes),28 mutations associated with constitutive activation of NFkB and JAK-STAT signalling pathways and changes associated with immune evasion. There are frequent copy number alterations, mainly at 9p24 involving CD274/PDCD1LG2 and at 2p16/REL , and, in a minority, CIITArearrangement.25,29-31 Abnormalities of MAPK/ERK, PI3K/AKT, and NOTCH1 pathways may also contribute to the pathogenesis of cHL.31 |
| Mediastinal gray zone lymphoma (MGZL) | MGZL is a B-cell neoplasm with pathologic features, including genetic features, that overlap with both PMBCL and cHL, suggesting a common or similar origin.13,32 SOCS1, GNA13, TNFAIP3, NFKBIE and XPO1 are the genes most commonly mutated. NFkB and JAK-STAT signalling pathways are activated. Translocations of BCL2/BCL6 are virtually absent.2,33,34. There are rare cases of extramediastinal lymphomas with some features of gray zone lymphoma, but BCL2, TP53 and CREBBP mutations are significantly more common in nonthymic cases, and a subset of cases has translocations of BCL2 or BCL6.2,35 Overall these extramediastinal lymphomas are better classified as diffuse large B-cell lymphoma, NOS. |
| Mediastinal follicular dendritic cell sarcoma (FDCS) | Rare cases of mediastinal FDCS are described, including rare cases arising from hyaline-vascular Castleman disease.36 No studies of molecular genetic features focusing specifically on mediastinal FDCS are available. In FDCS in general, karyotypes have often been complex.37 Recurrent mutations in NFkB pathway genes and tumor suppressor genes are commonly found.38-40 Other alterations are uncommon. In contrast to histiocytic neoplasms, MAPK pathway mutations are typically absent,5 although BRAF V600E has been reported rarely.41 |
| Mediastinal myeloid sarcoma (MS) | Mediastinal MS occurring as an isolated tumor and also preceding a diagnosis of acute myeloid leukemia (AML) with bone marrow +/- blood involvement has been reported.6 Detailed genetic findings are often not available, but many are reported to have a complex karyotype.6 Individual cases of mediastinal MS have shown: FUS::ERG,42 ASXL1p.R693X mutation; 43 and t(10; 11)(p12;q21) associated with PICALM::MLLT10 fusion with TP53 mutation.44 A mediastinal MS showing 2 distinct FLT3 mutations is reported. The MS was refractory to treatment and a second biopsy showed persistent disease with a FLT3-TKD mutation, a TP53 mutation and an EP300 mutation, as well as aberrant clonal rearrangement of T-cell receptor genes.45 A pediatric case of AML with NPM1 mutation that relapsed as an isolated mediastinal MS has been described.46 A case of AML accompanied by MS in multiple sites, including the mediastinum, with a t(8:21), associated to RUNX1::RUNX1T1 fusion, is reported.47 |
Article Bibliography
| Reference Number | Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|---|
| 1 | 37835560 | 2023 | Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas. | Donzel M et al |
| 2 | 32961552 | 2021 | Mutational landscape of gray zone lymphoma. | Sarkozy C et al |
| 3 | 23320886 | 2013 | Thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a gene methylation study. | Takino H et al |
| 4 | 27041168 | 2016 | Thymic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue with 8q24 Abnormality. | Momoi A et al |
| 5 | 34837090 | 2021 | Follicular dendritic cell sarcoma. | Facchetti F et al |
| 6 | 17325888 | 2007 | Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature. | Ramasamy K et al |
| 7 | 15870177 | 2005 | NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. | Feuerhake F et al |
| 8 | 15044251 | 2004 | Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. | Guiter C et al |
| 9 | 16543468 | 2006 | Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. | Roberts RA et al |
| 10 | 20628145 | 2010 | Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. | Green MR et al |
| 11 | 26549456 | 2015 | Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. | Mottok A et al |
| 12 | 26608593 | 2016 | Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. | Mareschal S et al |
| 13 | 37530791 | 2023 | Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. | Gibson SE et al |
| 14 | 38055913 | 2024 | Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. | Noerenberg D et al |
| 15 | 33684939 | 2021 | Characterization of DLBCL with a PMBL gene expression signature. | Duns G et al |
| 16 | 11943727 | 2002 | Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. | Inagaki H et al |
| 17 | 22243778 | 2012 | Characterization of chromosomal aberrations in thymic MALT lymphoma. | Kominato S et al |
| 18 | 34605949 | 2022 | Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. | Wang X et al |
| 19 | 11943341 | 2002 | Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22). | Harigae H et al |
| 20 | 16353132 | 2006 | Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutated. | Yoshida M et al |
| 21 | 34074861 | 2021 | Mediastinal Lymphoproliferative Disorders. | Pina-Oviedo S et al |
| 22 | 19147408 | 2009 | Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. | Coustan-Smith E et al |
| 23 | 10419594 | 1999 | Gene rearrangements in T-cell lymphoblastic lymphoma. | Pilozzi E et al |
| 24 | 10361104 | 1999 | Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. | Szczepański T et al |
| 25 | 34175178 | 2024 | Aggressive Mediastinal Lymphomas. | Wang X et al |
| 26 | 18691165 | 2008 | Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. | Van Vlierberghe P et al |
| 27 | 21112032 | 2010 | Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. | Meijerink JP et al |
| 28 | 10637266 | 2000 | The molecular and cellular origins of Hodgkin's disease. | Staudt LM et al |
| 29 | 25488972 | 2015 | Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. | Reichel J et al |
| 30 | 21368758 | 2011 | MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. | Steidl C et al |
| 31 | 33686198 | 2021 | Molecular biology of Hodgkin lymphoma. | Weniger MA et al |
| 32 | 32914098 | 2020 | Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. | Pittaluga S et al |
| 33 | 21822207 | 2011 | Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. | Eberle FC et al |
| 34 | 30540571 | 2019 | Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA. | Sarkozy C et al |
| 35 | 32516416 | 2020 | Gene expression profiling of gray zone lymphoma. | Sarkozy C et al |
| 36 | 30646936 | 2019 | Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease. | Wu YL et al |
| 37 | 23422480 | 2013 | Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. | Perry AM et al |
| 38 | 26564005 | 2016 | Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes. | Griffin GK et al |
| 39 | 28621320 | 2017 | Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology. | Andersen EF et al |
| 40 | 33904632 | 2021 | Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. | Massoth LR et al |
| 41 | 24720374 | 2014 | Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. | Go H et al |
| 42 | 26770812 | 2016 | FUS-ERG gene fusion in isolated myeloid sarcoma showing uncommon clinical features. | Ueda R et al |
| 43 | 32286099 | 2020 | Somatic ASXL1 p.R693X mutation identified by next generation sequencing in isolated myeloid sarcoma involving the mediastinum. | Fang L et al |
| 44 | 30227397 | 2018 | Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene. | Naesens L et al |
| 45 | 34145177 | 2021 | Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangement. | Contejean A et al |
| 46 | 30859798 | 2019 | Isolated Mediastinal Myeloid Sarcoma after NPM1-Positive Pediatric Acute Myeloid Leukemia. | Tüfekçi Ö et al |
| 47 | 15735171 | 2005 | Massive myeloid sarcoma affecting the central nervous system, mediastinum, retroperitoneum, liver, and rectum associated with acute myeloblastic leukaemia: a case report. | Best-Aguilera CR et al |
Citation
Paola Dal Cin, PhD ; Judy A. Ferry
Hematolymphoid tumors of the mediastinum
Atlas Genet Cytogenet Oncol Haematol. 2024-05-09
Online version: http://atlasgeneticsoncology.org/solid-tumor/209213
